Proteomic measures of gamma oscillations.

Neuroscience

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 08 04 2019
revised: 23 05 2019
accepted: 06 08 2019
entrez: 10 9 2019
pubmed: 10 9 2019
medline: 10 9 2019
Statut: epublish

Résumé

Gamma oscillations serve complex processes, and the first stage of their generation is the reticular activating system (RAS), which mediates the gamma-activity states of waking and paradoxical sleep. We studied whether the pedunculopontine nucleus (PPN), part of the RAS in which every cell manifests intrinsic gamma oscillations, undergoes changes resulting in distinctive protein expression. We previously found that a histone deacetylation inhibitor, trichostatin A (TSA), acutely (30 min) blocked these oscillations. We developed a proteomic method for sampling stimulated and unstimulated PPN and determining protein expression in 1 mm punches of tissue from brain slices subjected to various treatments. We compared brain slices exposed for 30 min to TSA (unstimulated), to the cholinergic agonist carbachol (CAR), known to induce PPN gamma oscillations, or exposed to both TSA + CAR.Comparison with existing methods: Label-free proteomics provides an unbiased and sensitive method to detect protein changes in the PPN. Our approach is superior to antibody-based methods that can lack specificity and can only be done for known targets. Proteomics methods like these have been leveraged to study molecular pathways in numerous systems and disease states. Significant protein changes were seen in two functions essential to the physiology of the PPN: cytoskeletal and intracellular [Ca

Sections du résumé

BACKGROUND BACKGROUND
Gamma oscillations serve complex processes, and the first stage of their generation is the reticular activating system (RAS), which mediates the gamma-activity states of waking and paradoxical sleep. We studied whether the pedunculopontine nucleus (PPN), part of the RAS in which every cell manifests intrinsic gamma oscillations, undergoes changes resulting in distinctive protein expression.
NEW METHOD METHODS
We previously found that a histone deacetylation inhibitor, trichostatin A (TSA), acutely (30 min) blocked these oscillations. We developed a proteomic method for sampling stimulated and unstimulated PPN and determining protein expression in 1 mm punches of tissue from brain slices subjected to various treatments.
RESULTS RESULTS
We compared brain slices exposed for 30 min to TSA (unstimulated), to the cholinergic agonist carbachol (CAR), known to induce PPN gamma oscillations, or exposed to both TSA + CAR.Comparison with existing methods: Label-free proteomics provides an unbiased and sensitive method to detect protein changes in the PPN. Our approach is superior to antibody-based methods that can lack specificity and can only be done for known targets. Proteomics methods like these have been leveraged to study molecular pathways in numerous systems and disease states.
CONCLUSIONS CONCLUSIONS
Significant protein changes were seen in two functions essential to the physiology of the PPN: cytoskeletal and intracellular [Ca

Identifiants

pubmed: 31497668
doi: 10.1016/j.heliyon.2019.e02265
pii: S2405-8440(19)35925-0
pii: e02265
pmc: PMC6722265
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e02265

Références

Science. 1999 Apr 2;284(5411):162-6
pubmed: 10102820
Biochemistry. 2001 Jul 10;40(27):8152-60
pubmed: 11434785
J Neurosci Res. 2002 Nov 15;70(4):611-21
pubmed: 12404515
Anal Chem. 2003 Sep 1;75(17):4646-58
pubmed: 14632076
J Bioenerg Biomembr. 2003 Dec;35(6):639-47
pubmed: 15000524
J Neurosci Methods. 2004 Mar 15;134(1):9-21
pubmed: 15102499
Brain Res. 1992 Jan 13;569(2):210-20
pubmed: 1540827
J Proteome Res. 2006 Sep;5(9):2339-47
pubmed: 16944946
Neuroscience. 2007 Mar 30;145(3):841-50
pubmed: 17289272
Neuron. 2007 Feb 15;53(4):487-93
pubmed: 17296551
Neuron. 2007 Oct 4;56(1):94-108
pubmed: 17920018
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):17903-4
pubmed: 17989213
Nat Methods. 2009 May;6(5):359-62
pubmed: 19377485
Int J Psychophysiol. 2009 Sep;73(3):350-4
pubmed: 19481120
Neuroscience. 2009 Sep 29;163(1):397-414
pubmed: 19540313
J Neurosci. 2009 Jun 24;29(25):8288-97
pubmed: 19553468
Science. 2009 Aug 14;325(5942):834-40
pubmed: 19608861
Sleep. 2009 Sep;32(9):1191-200
pubmed: 19750924
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):897-901
pubmed: 1992481
Neuroimage. 2010 Feb 15;49(4):3257-68
pubmed: 19932756
J Neurophysiol. 2010 Jul;104(1):463-74
pubmed: 20463196
J Neural Transm (Vienna). 2011 Oct;118(10):1397-407
pubmed: 20936418
Eur J Neurosci. 2011 Aug;34(3):404-15
pubmed: 21722210
J Neurosci. 1990 Aug;10(8):2560-79
pubmed: 2201752
Hippocampus. 2012 Jul;22(7):1493-500
pubmed: 22161912
Brain Res. 1990 Sep 17;527(2):213-23
pubmed: 2253034
Eur J Neurosci. 2013 Apr;37(8):1330-9
pubmed: 23406153
J Proteomics Bioinform. 2013 Mar 1;6(3):43-50
pubmed: 23976835
J Appl Physiol (1985). 2013 Nov 1;115(9):1402-14
pubmed: 23990242
Front Neurol. 2013 Nov 06;4:176
pubmed: 24223570
PLoS One. 2013 Dec 30;8(12):e83919
pubmed: 24386308
J Neurosci. 2014 Mar 26;34(13):4708-27
pubmed: 24672016
Cell Calcium. 2014 May;55(5):269-80
pubmed: 24703904
Front Neurol. 2014 Oct 20;5:210
pubmed: 25368599
J Neurophysiol. 2015 Feb 1;113(3):709-19
pubmed: 25376789
Physiol Rep. 2015 Jun;3(6):null
pubmed: 26109189
Curr Biol. 2015 Aug 3;25(15):R677-91
pubmed: 26241148
J Biomol Screen. 2016 Jul;21(6):643-52
pubmed: 26858181
J Neural Transm (Vienna). 2016 Jul;123(7):667-678
pubmed: 27216823
Physiol Rep. 2016 Jun;4(12):null
pubmed: 27354537
Med Hypotheses. 2017 Jul;104:58-62
pubmed: 28673592
Proc Natl Acad Sci U S A. 1989 Mar;86(5):1698-702
pubmed: 2922407
Neurobiol Dis. 2019 Aug;128:31-39
pubmed: 29353013
Sci Rep. 2018 Sep 3;8(1):13156
pubmed: 30177751
Bipolar Disord. 2019 Mar;21(2):108-116
pubmed: 30506611
Biol Cybern. 1988;60(2):121-30
pubmed: 3228555
Annu Rev Physiol. 1993;55:349-74
pubmed: 8466179
J Cell Biol. 1997 Jul 28;138(2):375-84
pubmed: 9230079
Neuron. 1998 Sep;21(3):593-606
pubmed: 9768845

Auteurs

Stephanie D Byrum (SD)

Center for Translational Pediatric Research, Arkansas Children's Research Institute, Little Rock, AR, USA.

Charity L Washam (CL)

Center for Translational Pediatric Research, Arkansas Children's Research Institute, Little Rock, AR, USA.

Alan J Tackett (AJ)

Center for Translational Pediatric Research, Arkansas Children's Research Institute, Little Rock, AR, USA.

Edgar Garcia-Rill (E)

Center for Translational Neuroscience, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Veronica Bisagno (V)

ININFA, Argentina.

Francisco J Urbano (FJ)

IFIBYNE, CONICET, Universidad de Buenos Aires, Buenos Aires, Argentina.

Classifications MeSH